LPL Financial’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.2M Sell
344,539
-20,826
-6% -$1.39M 0.01% 1479
2026
Q1
$22.9M Buy
365,365
+180,471
+98% +$12.6M 0.01% 1369
2025
Q4
$12.3M Buy
184,894
+19,362
+12% +$1.25M ﹤0.01% 1754
2025
Q3
$11.1M Buy
165,532
+11,035
+7% +$873K ﹤0.01% 1768
2025
Q2
$13.5M Buy
154,497
+6,335
+4% +$497K ﹤0.01% 1509
2025
Q1
$10.1M Sell
148,162
-40,144
-21% -$3.28M ﹤0.01% 1594
2024
Q4
$14.6M Buy
188,306
+72,217
+62% +$5.35M 0.01% 1266
2024
Q3
$7.78M Buy
116,089
+30,914
+36% +$2.54M ﹤0.01% 1658
2024
Q2
$9.66M Buy
85,175
+35
+0% +$4.42K ﹤0.01% 1404
2024
Q1
$11.8M Buy
85,140
+14,697
+21% +$1.85M 0.01% 1228
2023
Q4
$8.74M Sell
70,443
-88,093
-56% -$9M 0.01% 1336
2023
Q3
$14.8M Buy
158,536
+4,177
+3% +$471K 0.01% 945
2023
Q2
$19.8M Buy
154,359
+13,501
+10% +$1.63M 0.01% 797
2023
Q1
$16.4M Buy
140,858
+1,239
+0.9% +$139K 0.01% 850
2022
Q4
$15.8M Buy
139,619
+21,436
+18% +$2.35M 0.01% 814
2022
Q3
$9.52M Buy
118,183
+10,057
+9% +$852K 0.01% 986
2022
Q2
$8.13M Sell
108,126
-30,098
-22% -$2.75M 0.01% 1080
2022
Q1
$17.7M Buy
138,224
+15,264
+12% +$1.67M 0.02% 724
2021
Q4
$16.5M Buy
122,960
+30,496
+33% +$4.38M 0.01% 756
2021
Q3
$12.6M Buy
92,464
+15,708
+20% +$1.98M 0.01% 828
2021
Q2
$8.19M Buy
76,756
+27,144
+55% +$2.61M 0.01% 1026
2021
Q1
$4.46M Sell
49,612
-9,328
-16% -$876K 0.01% 1309
2020
Q4
$5.45M Sell
58,940
-19,504
-25% -$1.74M 0.01% 1071
2020
Q3
$8.08M Sell
78,444
-16,456
-17% -$1.72M 0.01% 726
2020
Q2
$9.62M Buy
94,900
+45,480
+92% +$4.07M 0.02% 599
2020
Q1
$3.33M Buy
49,420
+11,124
+29% +$692K 0.01% 915
2019
Q4
$2.09M Buy
38,296
+7,604
+25% +$361K ﹤0.01% 1323
2019
Q3
$1.15M Buy
30,692
+1,792
+6% +$69.6K ﹤0.01% 1626
2019
Q2
$1.08M Sell
28,900
-1,136
-4% -$35.7K ﹤0.01% 1665
2019
Q1
$894K Sell
30,036
-2,448
-8% -$86K ﹤0.01% 1729
2018
Q4
$973K Buy
32,484
+1,992
+7% +$63.2K ﹤0.01% 1561
2018
Q3
$1.09M Sell
30,492
-1,980
-6% -$61.4K ﹤0.01% 1617
2018
Q2
$771K Buy
32,472
+292
+0.9% +$6.19K ﹤0.01% 1828
2018
Q1
$597K Sell
32,180
-34,324
-52% -$508K ﹤0.01% 1998
2017
Q4
$954K Sell
66,504
-17,524
-21% -$228K ﹤0.01% 1554
2017
Q3
$1.03M Buy
84,028
+21,244
+34% +$376K ﹤0.01% 1409
2017
Q2
$1.15M Sell
62,784
-51,088
-45% -$944K ﹤0.01% 1288
2017
Q1
$2.39M Buy
113,872
+60,664
+114% +$1.18M 0.02% 737
2016
Q4
$775K Buy
53,208
+23,448
+79% +$415K 0.01% 1385
2016
Q3
$611K Buy
+29,760
New +$662K 0.01% 1546
2015
Q4
Sell
-9,528
Closed -$202K 3184
2015
Q3
$202K Sell
9,528
-1,040
-10% -$23.2K ﹤0.01% 2503
2015
Q2
$211K Buy
+10,568
New +$186K ﹤0.01% 2585

Other funds holding DXCM

LPL Financial's DXCM Position: Q2 2026 in Review

LPL Financial reduced its DexCom (DXCM) stake by 5.7% in Q2 2026, selling an estimated $1.39M and leaving 344,539 shares worth $23.2M. The position accounts for 0.01% of the portfolio, ranked #1479.

LPL Financial first reported a position in DXCM in Q2 2015 and has held it in 42 quarters since. 497 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • LPL Financial held 344,539 shares of DexCom worth $23.2M as of Q2 2026.
  • LPL Financial sold 20,826 DexCom shares in Q2 2026, an estimated $1.39M.
  • DexCom made up 0.01% of LPL Financial's portfolio in Q2 2026, its #1479 holding.
  • LPL Financial first reported a position in DexCom in Q2 2015 and has held it in 42 quarters since.
  • 497 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.